N1,N3-Bis(2,2,6,6-tetramethylpiperidin-4-yl)isophthalamide, 99+%, 100g

2-Methylthiophene-3-carbaldehyde, 97%, 250mg

4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine, 95%, 1g

(r)-2-Amino-2-(3,5-dimethylphenyl)ethan-1-ol, 98%, 100mg

N1-(4-Chlorobenzyl)-N2,N2-dimethyl-N1-(pyridin-2-yl)ethane-1,2-diamine hydrochloride, 95.0%, 50mg

Ethyl 2-aminothiazole-5-carboxylate hydrochloride, 95.0%, 1g

5-Bromo-1,7-naphthyridine-3-carboxylic acid, 98%, 250mg

2-Ethyl-3,5-dimethylpyrazine, 95.0%, 1g

Dimethyl[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]amine, 95.0%, 25g

4'-(tert-Butyl)-[1,1'-biphenyl]-4-carboxylic acid, 95.0%, 5g

5-Methyl-benzo[b]thiophene-2-carboxylic acid ethyl ester, 95.0%, 100g

(2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(aminomethyl)tetrahydrofuran-3,4-diol, 95+%, 5mg

2-Nitrophenyl-beta-D-glucopyranoside, min. 99%, for biochemistry, 500 mg, glass packaging